• 1
    Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol. 2000; 183: 19.
  • 2
    Baserga R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene. 2000; 19: 55745581.
  • 3
    LeRoith D. Insulin-like growth factors and cancer. Ann Intern Med. 1995; 122: 5459.
  • 4
    Ferry RJ Jr., Cerri RW, Cohen P. Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res. 1999; 51: 5367.
  • 5
    Singh P, Rubin N. Insulin-like growth factors and binding proteins in colon cancer. Gastroenterology. 1993; 105: 12181237.
  • 6
    Bustin SA, Jenkins PJ. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med. 2001; 7: 447454.
  • 7
    Ma J, Pollak M, Giovannucci E, et al. A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res. 2000; Suppl A: 2829.
  • 8
    Townsend CM, Singh P, Thompson JC. Effects of gastrointestinal peptides on gastrointestinal cancer growth. Gastroenterol Clin North Am. 1989; 18: 777791.
  • 9
    Lahm H, Svardet L, Laurent PL, et al. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor α. Br J Cancer. 1992; 65: 341346.
  • 10
    Akagi Y, Liu W, Zebrowski B, Xie K, Ellis LM. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res. 1998; 58: 40084014.
  • 11
    Wong BCY, Michell NP, Lewis AE, Watters D, Langman MJS, Eggo Mc. IGF-I rescues colonic cells from apoptosis induced by protein kinase C activators and indomethacin [abstract]. 79th Annual Meeting of the Endocrine Society, Minneapolis, 1997: P1–195.
  • 12
    Lambert S, Vivario J, Bonviver J, Gol-Winkler R. Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. Int J Cancer. 1990; 46: 405410.
  • 13
    Lambert S, Collette J, Gillis J, Franchimont P, Desaive C, Gol-Winkler R. Tumor IGF-II content in a patient with colon adenocarcinoma correlates with abnormal expression of the gene. Int J Cancer. 1991; 48: 826830.
  • 14
    Tricoli JV, Rall LB, Karakousis CP, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 1986; 46: 61696173.
  • 15
    Singh P, Dai B, Given RL, Lu X, Holthuizen PE. Differential activation of IGF-II promoters p3 and p4 in caco-2 cells during growth and differentiation. Gastroenterology. 1998; 114: 12211229.
  • 16
    El Atiq F, Garrouste F, Remacle-Bonnet M, Sastre B, Pommier G. Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer. Int J Cancer. 1994; 57: 491497.
  • 17
    Michell NP, Langman MJS, Eggo MC. Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. Br J Cancer. 1997; 76: 6066.
  • 18
    Guo YS, Narayan S, Yallampalli C, Singh P. Characterization of insulin-like growth factor I receptors in human colon cancer. Gastroenterology. 1992; 102: 11011198.
  • 19
    Rouyer-Fessard C, Gammeltoft S, Laburthe M. Expression of two types of receptor for insulin-like growth factors in human colonic epithelium. Gastroenterology. 1990, 98: 703707.
  • 20
    Remacle-Bonnet MM, Culouscou JM, Garrouste FL, Rabenandrasana C, Marvaldi JL, Pommier GJ. Expression of type 1, but not type II insulin-like growth factor receptors on both undifferentiated and differentiated HT29 human colon carcinoma cell line. J Clin Endocrinol Metab. 1992; 75: 609616.
  • 21
    Zenilman ME, Graham W. Insulin-like growth factor I receptor messenger RNA in the colon is unchanged during neoplasia. Cancer Invest. 1997; 15: 17.
  • 22
    Adenis A, Peyrat JP, Hecquet B, et al. Type I insulin-like growth factor receptors in human colorectal cancer. Eur J Cancer. 1995; 31A: 5055.
  • 23
    Mishra L, Bass B, Ooi BS, Sidaway A, Korman L. Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers. Growth Horm IGF Res. 1998; 8: 473479.
  • 24
    Freier S, Weiss O, Eran M, et al. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut. 1999; 44: 704708.
  • 25
    Hakam A, Yeatman J, Lu L, et al. Expression of insulin-like growth factor-1 receptors in human colorectal cancer. Hum Pathol. 1999; 30: 11281133.
  • 26
    Jass JR, Sobin LH. Histological typing of intestinal tumors. World Health Organization. International classification of tumors. New York: Springer, 1989.
  • 27
    Zhang W, Thorton WH, MacDonald RS. Insulin-like growth factor-I and II receptor expression in rat colon mucosa are affected by dietary lipid intake. J Nutr. 1998; 182: 158165.
  • 28
    Kutoh E, Boss O, Levasseur M, Giacobino JP. Quantification of the full length leptin receptor (OB-Rb) in human brown and white adipose tissue. Life Sci. 1998; 62: 445451.
  • 29
    Gilliland G, Perrin S, Blanchard K, Bunn HF. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA. 1990; 87: 27252729.
  • 30
    Alms WJ, Braun-Elwert L, James SP, Yurovsky VV, White B. Simultaneous quantitation of cytokine mRNAs by reverse transcription-polymerase chain reaction using multiple internal standard cRNAs. Diagn Mol Pathol. 1996; 5: 8897.
  • 31
    Ullrich A, Gray A, Tam AW, et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specifity. EMBO J. 1986; 5: 25032512.
  • 32
    Bell GI, Merryweather JP, Sanchez-Pescador R, et al. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature. 1984; 310: 775777.
  • 33
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162: 156159.
  • 34
    Weber MM, Auernhammer CJ, Kiess W, Engelhardt D. Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands. Eur J Endocrinol. 1997; 136: 296303.
  • 35
    Scatchard G. The attraction of proteins for small molecules and ions. Ann N Y Acad Sci. 1949; 51: 660672.
  • 36
    Remacle-Bonnet M, Garrouste F, El Atiq F, Marvaldi J, Pommier G. Cell polarity of the insulin-like growth factor system in human intestinal epithelial cells. J Clin Invest. 1995; 96: 192200.
  • 37
    Kawamoto K, Onodera H, Kan S, Kondo S, Imamura M. Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma. Cancer. 1999; 85: 1825.
  • 38
    Hoeflich A, Yan Y, Kessler U, Heinz-Erian P, Kolb H, Kiess W. Human colon carcinoma cells (CaCo2) synthesize IGF-II and express IGF-I receptors and IGF-II/M6P receptors. Mol Cell Endocrinol. 1994; 101: 141150.
  • 39
    Kawamoto K, Onodera H, Kondo S, et al. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology. 1998; 55: 242248.
  • 40
    Hassan AB, Howell JA. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. Cancer Res. 2000; 60: 10701076.
  • 41
    Kaleko M, Rutter WJ, Miller AD. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol. 1990; 10: 464473.
  • 42
    Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res. 1995; 55: 37393741.
  • 43
    Long L, Nip J, Brodt P. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res. 1994; 54: 37323737.
  • 44
    Hoeflich A, Yang Y, Rascher W, et al. Coordinate expression of insulin-like growth factor II (IGF-II) and IGF-II/mannose-6-phosphate receptor mRNA and stable expression of IGF-I receptor mRNA during differentiation of human colon carcinoma cells (caco-2). Eur J Endocrinol. 1996; 135: 4959.
  • 45
    Lamonerie T, Lavialle C, De Galle B, Binoux M, Brison O. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line. Exp Cell Res. 1995; 216: 342351.
  • 46
    Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La CA. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci U S A. 2001; 98: 591596.
  • 47
    Winkler R, Delacroix L, Bensbaho K, Lambert S, Collette J, Hodzic D. IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement. Horm Metab Res. 1999; 31: 148154.
  • 48
    Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med. 1998; 4: 12761280.
  • 49
    Werner H, Le Roith D. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci. 2000; 57: 932942.